Neuroendocrine Tumor Research Foundation | Strategic Alliance Partners

Three Neuroendocrine Tumor Research Foundation grant winners outlined research that aimed to deliver biology-driven strategies to patients.

Lynette Fernandez-Cuesta, PhD, discussed how the Petersen Accelerator Grant will drive the development of real-time clinical biomarkers for aggressive lung NETs.

The NETRF lends funding to help discover new and emerging treatment options in neuroendocrine tumors, according to Anna Greene, PhD.

Anna Greene, PhD, spoke about how this under-studied disease needs increased funding and more awareness.

Anna Greene, PhD, highlights the NETRF’s role as the largest funder of NET research, their current research funding opportunities, and its commitment to patient support.